GT Biopharma (GTBP) Research & Development (2010 - 2026)
GT Biopharma's Research & Development came in at $413,000 for Q1 2026, down 62.4% from $1.1 million a year earlier and down 70.0% from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Research & Development (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Mar 31, 2026, GT Biopharma reported Research & Development of $2.79 million, down 54.5% year-over-year; for FY2025, it came in at $3.47 million, down 40.1% from FY2024.
- Research & Development has declined in each of the last four years, though with a five-year compound annual growth rate of 48.2% (FY2020 to FY2025).
- Going back by year, Research & Development was $5.8 million in FY2024 (-10.3%), $6.47 million in FY2023 (-26.6%), $8.81 million in FY2022 (-8.1%) and $9.59 million in FY2021.
- The five-year range for quarterly Research & Development is $363,000 (Q2 2025) to $6.3 million (Q4 2021).
- Year-over-year, Research & Development has declined for four consecutive quarters, with an average decline of 19.7% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in Q3 2022 (growth of 172.1%), and the weakest in Q2 2025 (a decline of 79.7%).
- Business Quant data shows GTBP's Research & Development at $1.38 million (Q4 2025), $634,000 (Q3 2025) and $363,000 (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | GT Biopharma | 9.57 Mn | 9.57 Mn | - | 413,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 413,000.00 |
| Dec 31, 2025 | 1.38 Mn |
| Sep 30, 2025 | 634,000.00 |
| Jun 30, 2025 | 363,000.00 |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 1.93 Mn |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 1.78 Mn |
| Mar 31, 2024 | 777,000.00 |
| Dec 31, 2023 | 1.36 Mn |
| Sep 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | 2.10 Mn |
| Mar 31, 2023 | 1.65 Mn |
| Dec 31, 2022 | 2.84 Mn |
| Sep 30, 2022 | 2.74 Mn |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 2.09 Mn |
| Dec 31, 2021 | 6.30 Mn |
| Sep 30, 2021 | 1.01 Mn |
| Jun 30, 2021 | 639,000.00 |
API Access
GT Biopharma Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();